Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 5, 2010, Pages 2180-2186

  Anderson, Helen ^a   Fogel, Naomi ^a   Grebe, Stefan K ^b   Singh, Ravinder J ^b   Taylor, Robert L ^b   Dunaif, Andrea ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; ANDROSTENEDIONE; ESTRADIOL; HYDROXYPROGESTERONE; PRASTERONE; TESTOSTERONE; ANDROGEN;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BIRTH WEIGHT; CASE CONTROL STUDY; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FETUS GROWTH; HUMAN; INFANT; LARGE FOR GESTATIONAL AGE; MAJOR CLINICAL STUDY; MALE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROGENY; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL; UMBILICAL CORD BLOOD; BLOOD; BODY MASS; BODY SIZE; CHEMISTRY; FETUS BLOOD; GESTATIONAL AGE; MATERNAL AGE; NEWBORN; REFERENCE VALUE; SMALL FOR DATE INFANT; WEIGHT GAIN;

MAMMALIA;

17-ALPHA-HYDROXYPROGESTERONE; ADULT; ANDROGENS; ANDROSTENEDIONE; BIRTH WEIGHT; BODY MASS INDEX; BODY SIZE; CASE-CONTROL STUDIES; ESTRADIOL; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MALE; MATERNAL AGE; POLYCYSTIC OVARY SYNDROME; REFERENCE VALUES; WEIGHT GAIN; YOUNG ADULT;

EID: 77952747569     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2651     Document Type: Article

References (40)

1. Ehrmann DA 2005 Polycystic ovary syndrome. N Engl J Med 352:1223-1236
2. Urbanek M, Sam S, Legro RS, Dunaif A 2007 Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. J Clin Endocrinol Metab 92:4191-4198
3. Biyasheva A, Legro RS, Dunaif A, Urbanek M 2009 Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2. J Clin Endocrinol Metab 94:2617-2625
4. Eagleson CA, Gingrich MB, Pastor CL, Arora TK, Burt CM, Evans WS, Marshall JC 2000 Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 85:4047-4052
5. Coviello AD, Legro RS, Dunaif A 2006 Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 91:492-497
6. Gambineri A, Patton L, Vaccina A, Cacciari M, Morselli-Labate AM, Cavazza C, Pagotto U, Pasquali R 2006 Treatment with flutamide, metformin and their combination added to hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. J Clin Endocrinol Metab 91:3970-3980
7. Hales CN, Barker DJ 2001 The thrifty phenotype hypothesis. Br Med Bull 60:5-20
8. Ehrenberg HM, Mercer BM, Catalano PM 2004 The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol 191:964-968 (Pubitemid 39298142)
9. Silverman BL, Rizzo TA, Cho NH, Metzger BE 1998 Long-term effects of the intrauterine environment. The Northwestern University Diabetes in Pregnancy Center. Diabetes Care 21(Suppl 2):B142-B149
10. Franks S 2009 Do animal models of polycystic ovary syndrome help to understand its pathogenesis and management? Yes, but their limitations should be recognized. Endocrinology 150:3983-3985
11. Ibáñez L, Jiménez R, de Zegher F 2006 Early puberty-menarche after precocious pubarche: relation to prenatal growth. Pediatrics 117:117-121
12. Ibáñez L, Jaramillo A, Enriquez G, Miró E, López-Bermejo A, Dunger D, de Zegher F 2007 Polycystic ovaries after precocious pubarche: relation to prenatal growth. Hum Reprod 22:395-400
13. Sir-Petermann T, Hitchsfeld C, Maliqueo M, Codner E, Echiburú B, Gazitúa R, Recabarren S, Cassorla F 2005 Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod 20:2122-2126
14. Abbott DH, Barnett DK, Bruns CM, Dumesic DA 2005 Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update 11:357-374
15. Bjercke S, Dale PO, Tanbo T, Storeng R, Ertzeid G, Abyholm T 2002 Impact of insulin resistance on pregnancy complications and outcome inwomenwith polycystic ovary syndrome. Gynecol Obstet Invest 54:94-98
16. Fridström M, Nisell H, Sjöblom P, Hillensjö T 1999 Are women with polycystic ovary syndrome at an increased risk of pregnancy-induced hypertension and/or preeclampsia. Hypertens Pregnancy 18:73-80 (Pubitemid 29149859)
17. Haakova L, Cibula D, Rezabek K, Hill M, Fanta M, Zivny J 2003 Pregnancy outcome in women with PCOS and in controls matched by age and weight. Hum Reprod 18:1438-1441
18. Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A 2001 Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 16:226-229
19. Legro RS, Roller RL, Dodson WC, Stetter CM, Kunselman AR, Dunaif A 2010 Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives. J Clin Endocrinol Metab 95:789-799
20. Oken E, Kleinman KP, Rich-Edwards J, Gillman MW 2003Anearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 3:6
21. Tapanainen J, Huhtaniemi I, Koivisto M, Kujansuu E, Tuimala R, Vihko R 1984 Hormonal changes during the perinatal period: FSH, prolactin and some steroid hormones in the cord blood and peripheral serum of preterm and full-term female infants. J Steroid Biochem 20:1153-1156
22. Cole B, Hensinger K, Maciel GA, Chang RJ, Erickson GF 2006 Human fetal ovary development involves the spatiotemporal expression of P450c17 protein. J Clin Endocrinol Metab 91:3654-3661
23. Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Pérez-Bravo F, Recabarren SE 2002 Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod 17:2573-2579 (Pubitemid 35174106)
24. Kallen CB 2004 Steroid hormone synthesis in pregnancy. Obstet Gynecol Clin North Am 31:795-816, x
25. Hercz P, Ungar L, Siklos P, Farquharson RG 1988 Unconjugated 17β-oestradiol and oestriol in maternal serum and in cord vein and artery blood at term and preterm delivery. Eur J Obstet Gynecol Reprod Biol 27:7-12
26. Troisi R, Potischman N, Roberts JM, Harger G, Markovic N, Cole B, Lykins D, Siiteri P, Hoover RN 2003 Correlation of serum hormone concentrations in maternal and umbilical cord samples. Cancer Epidemiol Biomarkers Prev 12:452-456
27. Finegan JA, Bartleman B, Wong PY 1989 A window for the study of prenatal sex hormone influences on postnatal development. J Genet Psychol 150:101-112
28. van de Beek C, Thijssen JH, Cohen-Kettenis PT, van Goozen SH, Buitelaar JK 2004 Relationships between sex hormones assessed in amniotic fluid, and maternal and umbilical cord serum: what is the best source of information to investigate the effects of fetal hormonal exposure? Horm Behav 46:663-669
29. Faupel-Badger JM, Hoover RN, Potischman N, Roberts JM, Troisi R 2009 Pregnancy weight gain is not associated with maternal or mixed umbilical cord estrogen and androgen concentrations. Cancer Causes Control 20:263-267
30. Hickey M, Sloboda DM, Atkinson HC, Doherty DA, Franks S, Norman RJ, Newnham JP, Hart R 2009 The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. J Clin Endocrinol Metab 94:3714-3720
31. Kuijper EA, Vink JM, Lambalk CB, Boomsma DI 2009 Prevalence of polycystic ovary syndrome in women from opposite-sex twin pairs. J Clin Endocrinol Metab 94:1987-1990
32. Cresswell JL, Barker DJ, Osmond C, Egger P, Phillips DI, Fraser RB 1997 Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet 350:1131-1135
33. Paradisi G, Fulghesu AM, Ferrazzani S, Moretti S, Proto C, Soranna L, Caruso A, Lanzone A 1998 Endocrine-metabolic features in women with polycystic ovary syndrome during pregnancy. Hum Reprod 13:542-546
34. Laitinen J, Taponen S, Martikainen H, Pouta A, Millwood I, Hartikainen AL, Ruokonen A, Sovio U, McCarthy MI, Franks S, Järvelin MR 2003 Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms. Int J Obes 27:710-715
35. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS 2006 A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 12:673-683 (Pubitemid 44605508)
36. Abrams BF, Laros Jr RK 1986 Prepregnancy weight, weight gain, and birth weight. Am J Obstet Gynecol 154:503-509.
37. Jolly MC, Sebire NJ, Harris JP, Regan L, Robinson S 2003 Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies. Eur J Obstet Gynecol Reprod Biol 111:9-14
38. Sir-Petermann T, Echiburú B, Maliqueo MM, Crisosto N, Sánchez F, Hitschfeld C, Cárcamo M, Amigo P, Pérez-Bravo F 2007 Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome. Hum Reprod 22:1830-1836
39. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA 2008 Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991-2002
40. Beck-Peccoz P, Padmanabhan V, Baggiani AM, Cortelazzi D, Buscaglia M, Medri G, Marconi AM, Pardi G, Beitins IZ 1991 Maturation of hypothalamic- pituitary-gonadal function in normal human fetuses: circulating levels of gonadotropins, their common α-subunit and free testosterone, and discrepancy between immunological and biological activities of circulating follicle-stimulating hormone. J Clin Endocrinol Metab 73:525-532